# BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

> **NCT02940002** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 23 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** BAY1003803
- **DRUG:** Clobetasol propionate
- **DRUG:** Betamethasone/calcipotriene

## Key facts

- **NCT ID:** NCT02940002
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-12
- **Primary completion:** 2017-01-27
- **Final completion:** 2017-03-17
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02940002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02940002, "BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02940002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*